Latest ROE for Roche Holding AG: 66.85% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow66.85%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Roche Holding AG (RHHVF) currently reports a ROE of 66.85%. That is above the Healthcare sector average of 20.86%. Use the charts on this page to explore Roche Holding AG's ROE history and peer comparisons.
Roche Holding AG's ROE of 66.85% is higher than the Healthcare sector average of 20.86%. That is roughly 220.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Roche Holding AG's current 66.85% should be judged against Healthcare norms (sector average: 20.86%) and against RHHVF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 66.85%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.86%. From there, open related valuation or income-statement pages for Roche Holding AG, and consider following RHHVF for alerts when major investors trade the stock.
Roche Holding AG is classified in the Healthcare sector. On ROE, it currently shows 66.85% versus a sector average near 20.86%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RHHVF with unrelated industries.